J Knee Surg 2021; 34(04): 460-463
DOI: 10.1055/s-0039-1696975
Original Article

Narcotic-Free Perioperative Total Knee Arthroplasty: Does the Periarticular Injection Medication Make a Difference?

J. Schneider
1   Department of GME Orthopedic Surgery, MountainView Regional Medical Center, Graduate Medical Education, Las Cruces, New Mexico
,
B. Broome
2   Department of Orthopaedics, San Antonio Orthopaedic Specialists, San Antonio, Texas
,
D. Keeley
3   MountainView Regional Medical Center, Graduate Medical Education, Las Cruces, New Mexico
› Author Affiliations

Abstract

Multimodal pain management strategies are critical in total knee arthroplasty (TKA). There has recently been a shift toward opioid sparing protocols, yet most publications continue to use narcotics in the perioperative period. Periarticular injections are a popular adjunct but studies regarding the optimal medications have high variability making it difficult to choose the optimal medication. The purpose of this study is to validate a perioperative, opioid-free protocol and compare two different periarticular injections without the variability in previous reports. A multimodal pain protocol was instituted that administered no narcotic medications in the perioperative period. Over 2 years, primary TKA patients were informally randomized to receive liposomal bupivacaine (LB), or a cocktail of medications (CO). A total of 189 patients were included: 101 patients in group LB and 88 patients in group CO. Postoperative opioid consumption, length of stay, and inpatient distance ambulated were compared across the two injection groups. In morphine milligram equivalents, group LB consumed a mean of 20.36 mg of oxycodone versus 23.18 mg in group CO (p = 0.543). For tramadol, group LB consumed 27.24 mg versus 28.69 mg in group CO (p = 0.714). Mean hospital stay was 1.70 days for group LB and 1.72 days for group CO (p = 0.811). Distance ambulated was 528.4ft for group LB and 499.8ft for group CO (p = 0.477). In the LB group, 50% of patients required no oxycodone, and 12% of them took neither oxycodone nor tramadol for pain. In the CO group, 40% declined oxycodone and 10% declined both oxycodone and tramadol. We successfully treated all patients without narcotic medications in the perioperative period. Although we saw trends for improvements in group LB, these were small and not clinically meaningful. It appears that both injections were effective. There is a significant cost difference and medications should be chosen based on surgeon preference and institutional needs.



Publication History

Received: 19 June 2019

Accepted: 05 August 2019

Article published online:
16 September 2019

© 2019. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Dalury DF, Lieberman JR, MacDonald SJ. Current and innovative pain management techniques in total knee arthroplasty. J Bone Joint Surg Am 2011; 93 (20) 1938-1943
  • 2 Parvizi J, Miller AG, Gandhi K. Multimodal pain management after total joint arthroplasty. J Bone Joint Surg Am 2011; 93 (11) 1075-1084
  • 3 Lee GC. What's new in adult reconstructive knee surgery. J Bone Joint Surg Am 2018; 100 (02) 166-175
  • 4 Mont MA, Beaver WB, Dysart SH, Barrington JW, Del Gaizo DJ. Local infiltration analgesia with liposomal bupivacaine improves pain scores and reduces opioid use after total knee arthroplasty: results of a randomized controlled trial. J Arthroplasty 2018; 33 (01) 90-96
  • 5 Barrington JW, Olugbode O, Lovald S, Ong K, Watson H, Emerson Jr RH. Liposomal bupivacaine: a comparative study of more than 1000 total joint arthroplasty cases. Orthop Clin North Am 2015; 46 (04) 469-477
  • 6 Snyder MA, Scheuerman CM, Gregg JL, Ruhnke CJ, Eten K. Improving total knee arthroplasty perioperative pain management using a periarticular injection with bupivacaine liposomal suspension. Arthroplast Today 2016; 2 (01) 37-42
  • 7 Barrington JW, Emerson RH, Lovald ST, Lombardi AV, Berend KR. No difference in early analgesia between liposomal bupivacaine injection and intrathecal morphine after TKA. Clin Orthop Relat Res 2017; 475 (01) 94-105
  • 8 Heim EA, Grier AJ, Butler RJ, Bushmiaer M, Queen RM, Barnes CL. Use of liposomal bupivacaine instead of an epidural can improve outcomes following total knee arthroplasty. J Surg Orthop Adv 2015; 24 (04) 230-234
  • 9 Bagsby DT, Ireland PH, Meneghini RM. Liposomal bupivacaine versus traditional periarticular injection for pain control after total knee arthroplasty. J Arthroplasty 2014; 29 (08) 1687-1690
  • 10 Schwarzkopf R, Drexler M, Ma MW. et al. Is there benefit of Liposomal Bupivacaine compared to a traditional periarticular injection in total knee arthroplasty patients with a history of chronic opioid use?. J Arthroplasty 2016; 31 (08) 1702-1705
  • 11 Amundson AW, Johnson RL, Abdel MP. et al. A three-arm randomized clinical trial comparing continuous femoral plus single-injection sciatic peripheral nerve blocks versus peri- articular injection with ropivacaine or liposomal bupivacaine for patients undergoing total knee arthroplasty. Anesthesiology 2017; 126 (06) 1139-1150
  • 12 Alijanipour P, Tan TL, Matthews CN. et al. Periarticular injection of liposomal bupivacaine offers no benefit over standard bupivacaine in total knee arthroplasty: a prospective, randomized, controlled trial. J Arthroplasty 2017; 32 (02) 628-634
  • 13 Jain RK, Porat MD, Klingenstein GG, Reid JJ, Post RE, Schoifet SD. The AAHKS clinical research award: liposomal bupivacaine and periarticular injection are not superior to single-shot intra-articular injection for pain control in total knee arthroplasty. J Arthroplasty 2016; 31 (9, Suppl): 22-25
  • 14 Connelly JO, Edwards PK, Mears SC, Barnes CL. Technique for periarticular local infiltrative anesthesia delivery using liposomal bupivacaine in total knee arthroplasty. J Surg Orthop Adv 2015; 24 (04) 263-266
  • 15 Joshi GP, Cushner FD, Barrington JW. et al. Techniques for periarticular infiltration with liposomal bupivacaine for the management of pain after hip and knee arthroplasty: a consensus recommendation. J Surg Orthop Adv 2015; 24 (01) 27-35
  • 16 Meneghini RM, Bagsby D, Ireland PH, Ziemba-Davis M, Lovro LR. Liposomal bupivacaine injection technique in total knee arthroplasty. J Knee Surg 2017; 30 (01) 88-96
  • 17 Broome CB, Burnikel B. Novel strategies to improve early outcomes following total knee arthroplasty: a case control study of intra articular injection versus femoral nerve block. Int Orthop 2014; 38 (10) 2087-2089